Skip to main content

Table 1

From: Monitoring of immunity against leukemia stem cell in CML patients after cessation of TKI

Patients 0m 3m 6m Clinical course
1 - - - Molecular relapse
2 - - - CMR
3 - - + CMR
4 - - - CMR
5 - - - CMR
6 - + - CMR
7 - - - CMR
8 - - - Molecular relapse
9 - - - CMR
10 - - - CMR
11 - - - Molecular relapse
12 - - - Molecular relapse
13 - - - CMR
14 + - - CMR
15 - - - CMR
16 - - - CMR